Medical Pack

Details

Category: General

Published on Monday, 11 August 2008 14:19

Hits: 102447

References

1. EXPERT PANEL AND CONSENSUS PANEL MYOPAIN 1992. CONSENSUS DOCUMENT ON FIBROMYALGIA: THE COPENHAGEN DECLARATION. MUSCULOSKELETAL PAIN, MYOFASCIAL PAIN SYNDROME, AND THE FIBROMYALGIA SYNDROME. EDITED BY JACOBSEN, DANNESKIOLD-SAMSOE & LUND. NEW YORK, HAWORTH MEDICAL PRESS, 1992.
2. MACFARLANE: FMS AND CHRONIC WIDESPREAD PAIN. EPIDEMIOLOGY OF PAIN 1999; 113–123.
3. GOLDENBERG: FIBROMYALGIA SYNDROME A DECADE LATER. ARCHIVES OF INTERNAL MEDICINE 1999; 159: 777–785.
4. TURK ET AL: INTERDISCIPLINARY TREATMENT FOR FIBROMYALGIA SYNDROME: CLINICAL AND STATISTICAL SIGNIFICANCE. ARTHRITIS CARE RESEARCH 1998; 11: 186–195.
5. WOLF ET AL: THE AMERICAN COLLEGE OF RHEUMATOLOGY 1990 CRITERIA FOR THECLASSIFICATION OF FMS. ARTHRITIS & RHEUMATISM 1990; 33: 160–172.
6. WHITE ET AL: THE LONDON FIBROMYALGIA EPIDEMIOLOGY STUDY: COMPARING THEDEMOGRAPHIC AND CLINICAL CHARACTERISTICS IN 100 RANDOM COMMUNITY CASES OF  FIBROMYALGIA VERSUS CONTROLS. JOURNAL OF RHEUMATOLOGY 1999; 26: 1577–1585.
7. BENNETT: DISABLING FIBROMYALGIA: APPEARANCE VERSUS REALITY. JOURNAL OFRHEUMATOLOGY 1993; 20: 1821–1824.
8. WADDELL ET AL: OCCUPATIONAL HEALTH GUIDELINES FOR THE MANAGEMENT OF LOW BACK PAIN: AN INTERNATIONAL COMPARISON. OCCUPATIONAL ENVIRONMENTAL MEDICINE 2003; 60: 618–626.
9. MARCUS: CURRENT TRENDS IN FIBROMYALGIA RESEARCH. EXPERT OPINION IN PHARMACOTHERAPY 2003; 4: 1687–1695.
10. HENRIKSSON: FIBROMYALGIA – FROM SYNDROME TO DISEASE. OVERVIEW OF PATHOGENETIC MECHANISMS. JOURNAL OF REHABILITATION MEDICINE 2003; 41 (SUPPL): 89–94.
11. RUSSELL ET AL: ELEVATED CSF LEVELS OF SUBSTANCE P IN PATIENTS WITH FIBROMYALGIA SYNDROME. ARTHRITIS & RHEUMATISM 1994; 37: 1593–1601.
12. RUSSELL ET AL: INCREASED CONCENTRATIONS OF NGF IN THE CSF OF PATIENTS WITH FIBROMYALGIA. JOURNAL OF RHEUMATOLOGY 1999; 26: 1564–1569.
13. BENNETT: IMPAIRED GROWTH HORMONE SECRETION IN FIBROMYALGIA PATIENTS. ARTHRITIS & RHEUMATISM 2002; 46: 1344–1350.
14. MOLDOFSKY: ALPHA SLEEP CHARACTERISTICS IN FIBROMYALGIA. ARTHRITIS & RHEUMATISM 2001; 44: 222–230.
15. NEECK & RIEDEL: HORMONAL PERTURBATIONS IN FIBROMYALGIA SYNDROME. ANNUALS OF NEW YORK ACADEMY OF SCIENCE 1999; 876: 325–338.
16. BENGTSSON: THE MUSCLE IN FIBROMYALGIA. RHEUMATOLOGY 2002; 41: 721–724.
17. BENNETT ET AL: TRAMADOL & ACETAMINOPHEN TABLETS IN THE TREATMENT OFFIBROMYALGIA PAIN: A DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED STUDY.  AMERICAN JOURNAL OF MEDICINE 2003; 114: 537–545.
18. RAO & BENNETT: PHARMACOLOGICAL THERAPIES IN FIBROMYALGIA. BEST PRACTICE & RESEARCH CLINICAL RHEUMATOLOGY 2003; 17: 611–627.
19. MADDEN & HUNTER: A REVIEW OF THE ROLE OF THE GUT MICROFLORA IN IRRITABLE BOWEL SYNDROME AND THE EFFECT OF PROBIOTICS. BRITISH JOURNAL OF NUTRITION 2002; 88: S67–S72.
20. ROSSY ET AL: A META-ANALYSIS OF FIBROMYALGIA TREATMENT INTERVENTIONS.ANNUAL OF BEHAVIOURAL MEDICINE 1999; 21: 180–191.
21. GOWANS ET AL: EFFECT OF A RANDOMISED CONTROLLED TRIAL OF EXERCISE ON MOOD AND PHYSICAL FUNCTION IN INDIVIDUALS WITH FIBROMYALGIA. ARTHRITIS CARE & RESEARCH 2001;  45: 519–529.
22. HAKKINEN ET AL: STRENGTH TRAINING INDUCED ADAPTATIONS IN NEUROMUSCULARFUNCTION OF PREMENOPAUSAL WOMEN WITH FIBROMYALGIA: COMPARISON WITHHEALTHY WOMEN. ANNUAL FOR RHEUMATIC DISEASES 2001; 60: 21–26.
23. WHO 1986 THE OTTOWA CHARTER FOR HEALTH PROMOTION, OTTOWA, CANADA.
24. STRONG ET AL: PAIN: A TEXTBOOK FOR THERAPISTS 2002 EDITION, CHURCHILL LIVINGSTONE, ELSEVIER SCIENCE LTD PUBLISHERS, LONDON.
25. JENIFER CREEK: OCCUPATIONAL THERAPY: NEW PERSPECTIVES 1998 EDITION, WHURR PUBLISHERS, LONDON.
26. BUSKILA ET AL: JOINT HYPERMOBILITY AND FIBROMYALGIA IN SCHOOLCHILDREN. ANNUAL RHEUMATOLOGY DISSERTATIONS 1993; 52: 494–496.

Attachments:

Medical Pack

[Medical Pack for Download]

1119 kB